Sandra Gurrola
Equibles does not estimate personal net worth.
Get an email with a short summary when Ernexa Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ERNA alertsAbout Sandra Gurrola
Sandra Gurrola is recorded as CFO at Ernexa Therapeutics Inc. (ERNA) since May 5, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed June 26, 2026 that Sandra Gurrola resigned as Senior Vice President of Finance, effective July 3, 2026. Ernexa Therapeutics Inc. reported in an 8-K filed May 5, 2023 that Sandra Gurrola was appointed principal financial officer, effective May 5, 2023. The proxy statement of Ernexa Therapeutics Inc. reports total compensation of $374,246 for Sandra Gurrola in fiscal 2020, including a base salary of $190,000. Disclosed compensation is on record for 2 fiscal years. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Dr. Matthew Angel (CEO), Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member) and 7 others.
“On June 22, 2026, Sandra Gurrola, Senior Vice President of Finance of Ernexa Therapeutics Inc., a Delaware corporation (the "Company"), delivered her notice of resignation, with such resignation becoming effective July 3, 2026.”
“On May 4, 2023, the Board of Directors of Eterna Therapeutics Inc., a Delaware corporation (the “Company”), appointed Sandra Gurrola, the Company’s current Vice President, Finance (and principal accounting officer), as the Company’s principal financial officer, which appointment became effective on May 5, 2023.”
Affiliation history
-
Current
2023-05-05–present
-
Ernexa Therapeutics Inc. (ERNA)
Proxy statement
Start not stated–2026-07-03
-
Ernexa Therapeutics Inc. (ERNA)
Proxy statement
Start not stated–2021-03-25
Company network
Leadership on record at Ernexa Therapeutics Inc.
- Dr. Matthew Angel CEO
- Matt Angel, Ph.D. CEO
- Sanjeev Luther CEO, Board Member
- Allen Wolff Chairman, Board Member
- James Bristol Chairman
- Luba Greenwood Chairman, Board Member
- Dorothy Clarke General Counsel
- Brant C. Binder Board Member
- Dennis H. Langer Board Member
- Dorothy J. Clarke Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Ernexa Therapeutics Inc. (ERNA) | Vice President of Finance | $190,000 | $374,246 |
| 2019 | Ernexa Therapeutics Inc. (ERNA) | Vice President of Finance | $179,356 | $205,396 |